April 11, 2025 · STOCK Act disclosure
Representative Jefferson Shreve (Republican-IN) bought Amgen Inc., a stock transaction, valued at $15,001 - $50,000. The trade took place on April 11, 2025 and was disclosed on May 8, 2025 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.